HIF2α and NF-κB pathways also play an important role in RCC metastasis, due to the activation of metastasis-associated enhancer (MAE), which amplifies the expression of chemokine receptor CXCR4, thereby inducing pro-metastatic activity [148]. The gene discussed is NFKB1; the disease is renal cell carcinoma.